CME Group (CME) Receives a Hold from Oppenheimer

In a report released today, Owen Lau from Oppenheimer maintained a Hold rating on CME Group (CMEResearch Report). The company’s shares closed last Wednesday at $201.26.

According to TipRanks.com, Lau is a 4-star analyst with an average return of 14.3% and a 84.8% success rate. Lau covers the Financial sector, focusing on stocks such as Intercontinental Exchange, Victory Capital Holdings, and Focus Financial Partners.

Currently, the analyst consensus on CME Group is a Moderate Buy with an average price target of $212.67.

See today’s analyst top recommended stocks >>

CME Group’s market cap is currently $73.53B and has a P/E ratio of 34.90. The company has a Price to Book ratio of -11.27.

Based on the recent corporate insider activity of 110 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CME in relation to earlier this year. Last month, Sean Tully, the Sr MD Global Hd Financial & OT of CME bought 4,120 shares for a total of $224,004.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

CME Group Inc., formerly known as Chicago Mercantile Exchange Holdings Inc, is the world’s leading derivatives marketplace, with it offering a wide range of futures and options products for risk management. These include equity indexes, interest rates, agricultural commodities, foreign exchange, energy, and metals. The company also offers clearing and settlement services for exchange-traded contracts, as well as for cleared over-the-counter derivatives transactions. It also provides a wide range of market data services such as live quotes, delayed quotes, historical data service and market reports.